Ganoderma Polysaccharide Improves mRNA-LNP Efficacy
2026-09-17
The 2026 Pharmaceutics study identifies Ganoderma lucidum polysaccharide (GLP) as an adjuvant that improves mRNA-LNP protein expression while reducing oxidative stress. Its central contribution is a relatively simple formulation strategy that combines LNP delivery with redox regulation, although broader validation is still needed before applying the approach across cell types, cargos, and in vivo settings.
Aprotinin: Designing Protease-Controlled Assays
2026-09-17
Aprotinin, or bovine pancreatic trypsin inhibitor, is more than a fibrinolysis inhibitor: it is a reversible perturbation tool for separating protease-driven effects from assay artifacts. This guide integrates cardiovascular research, inflammatory readouts, and GRO-seq-informed experimental design.
How Impending Cell Death Generates Metastatic States
2026-09-16
Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving an impending-death experience can become stable prometastatic cells, termed PAMEs, rather than simply returning to a pre-treatment state. Their study links PAME formation to ER stress, PERK-CHOP signaling, GLI and NANOG-associated reprogramming, and a cytokine-mediated interaction with neighboring PIM cells.
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer
2026-09-16
This FASEB Journal study developed chemically modified p21 mRNA–loaded lipid nanoparticles for localized intravesical treatment of bladder cancer. The work links restored nuclear p21 expression to cell-cycle inhibition, DNA-damage signaling, apoptosis, and tumor suppression in an orthotopic mouse model, while highlighting the translational value of bladder-directed delivery.
Protease Inhibitor Cocktail: Protecting Assay Truth
2026-09-15
Discover how the Protease Inhibitor Cocktail supports reliable protein extraction, phosphorylation-sensitive assays, Western blotting, and co-immunoprecipitation. This article connects pre-analytical protein preservation with insights from a recent melatonin-hydrogel study in atopic dermatitis.
Sulfo-NHS-SS-Biotin: Practical Labeling Guide
2026-09-15
Sulfo-NHS-SS-Biotin is a water-compatible, amine-reactive reagent for labeling accessible primary amines on proteins and cell-surface molecules, with a reducible disulfide bond for label removal. It is suitable for controlled biotinylation, affinity capture, and detection, but should not be treated as a stable aqueous stock or assumed to label intracellular proteins in intact cells.
Sulfo-NHS-SS-Biotin: Practical Labeling Guide
2026-09-14
Sulfo-NHS-SS-Biotin is a water-compatible, amine-reactive reagent for labeling proteins and accessible cell-surface primary amines with a cleavable biotin handle. It is suitable for affinity capture and reversible protein purification, but not for intracellular labeling in intact cells or workflows that require a permanently attached biotin tag.
Peptidisc-Assisted Nanobody Clustering
2026-09-14
The reference preprint introduces peptidisc-assisted hydrophobic clustering as a way to assemble nanobodies into soluble multimeric, bispecific, and autofluorescent proteins. By coupling nanobodies to a transmembrane segment and stabilizing the resulting associations with peptidisc, the study uses avidity to improve target recognition while expanding protein-engineering options beyond tandem fusion and scaffold-based assembly.
Protease Inhibitor Cocktail for Reliable Cell Assays
2026-09-13
This scenario-driven guide explains how Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), SKU K1010, can stabilize protein measurements associated with cell viability, proliferation, and cytotoxicity experiments. It covers EDTA compatibility, 1:100 use, workflow controls, vendor-selection criteria, and limitations when interpreting phosphorylation or T-cell signaling data.
Cyanidin Chloride for Reliable Cell Assays
2026-09-12
This scenario-based guide explains how Cyanidin Chloride (SKU N2525) can be integrated into oxidative stress, viability, proliferation, and cytotoxicity workflows. It emphasizes identity control, solvent compatibility, assay-interference controls, and evidence-based interpretation for more reproducible laboratory decisions.
Viperin Targets Coronavirus nsp8 to Disrupt RTC Assembly
2026-09-11
The reference study identifies a nonenzymatic antiviral role for viperin: direct binding to coronavirus nsp8 destabilizes replication-transcription complex assembly and reduces RNA-dependent RNA polymerase activity. Using porcine deltacoronavirus as a model, the work separates this protein-interaction mechanism from ddhCTP-mediated RNA chain termination and highlights nsp8 as a possible broad-spectrum antiviral target.
AR Heterogeneity Shapes Enzalutamide Response in PCa
2026-09-11
The reference study shows that androgen receptor heterogeneity is not merely a descriptive feature of advanced prostate cancer: nuclear AR-positive and AR-low or AR-negative cell populations exhibit different tumor behavior and treatment responses. By combining patient tissue profiling, engineered LNCaP models, xenografts, transcriptomics, and combination therapy experiments, the authors identify BCL-2 as a candidate vulnerability for AR-low castration-resistant disease.
JSH-23: A Practical NF-κB Inhibitor Guide
2026-09-10
JSH-23 offers a focused way to test NF-κB p65 nuclear localization and transcriptional activity without directly preventing IκB degradation. This guide connects macrophage assays, cytokine profiling, and a cisplatin-induced acute kidney injury model with practical dosing, controls, and troubleshooting strategies.
Mycophenolic Acid: Reading Immunometabolic Assays
2026-09-10
Mycophenolic acid is more than a dehydrogenase inhibitor: it is a mechanistic probe for connecting nucleotide metabolism with immune-cell behavior. This guide explains how to interpret whole-blood stimulation results, control experimental confounding, and select meaningful orthogonal readouts.
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-09-09
Build cleaner delivery, translation, viability, and imaging experiments with a Cap1- and poly(A)-optimized luciferase transcript. This workflow also shows how to use the reporter as an orthogonal control when studying sequence-dependent innate immune responses to intracellular ssDNA.